Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romain Mathieu

Showing results (191-200 of 221) with videos related to

Pageof 23
Sort By:
European Urology|April 10, 2020
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node DissectionGiorgio Gandaglia, Alberto Martini, Guillaume Ploussard, et al.
European Urology Oncology|September 16, 2020
Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic ReviewGiancarlo Marra, Massimo Valerio, Isabel Heidegger, et al.
International Journal of Cancer|September 14, 2016
Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potentialSolène-Florence Kammerer-Jacquet, Laurence Crouzet, Angélique Brunot, et al.
Cancers|September 10, 2021
Biomarker in Active Surveillance for Prostate Cancer: A Systematic ReviewCécile Manceau, Gaëlle Fromont, Jean-Baptiste Beauval, et al.
Annals of Surgical Oncology|July 15, 2016
Comparison of 1800 Robotic and Open Partial Nephrectomies for Renal TumorsBenoit Peyronnet, Thomas Seisen, Emmanuel Oger, et al.
World Journal of Urology|June 9, 2016
HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC)Francesco Soria, Marco Moschini, Andrea Haitel, et al.
European Urology Oncology|January 4, 2026
Results of the Randomized Phase 3 AFU-GETUG-20 Trial Evaluating Adjuvant Leuprorelin Acetate After Radical Prostatectomy in Men with High-risk Localized Prostate CancerFrançois Rozet, Alain Ruffion, Pablo Lemercier, et al.
World Journal of Urology|October 27, 2014
Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomyRomain Mathieu, Shahrokh F Shariat, Christian Seitz, et al.
World Journal of Urology|May 23, 2016
Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomyMihai Dorin Vartolomei, Romain Mathieu, Vitaly Margulis, et al.
World Journal of Urology|November 7, 2022
Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimensAlberto Martini, Alae Touzani, Jean-Baptiste Beauval, et al.
Pageof 23

Showing results (191-200 of 221) with videos related to

Sort By:
Pageof 23
European Urology|April 10, 2020
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node DissectionGiorgio Gandaglia, Alberto Martini, Guillaume Ploussard, et al.
European Urology Oncology|September 16, 2020
Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic ReviewGiancarlo Marra, Massimo Valerio, Isabel Heidegger, et al.
International Journal of Cancer|September 14, 2016
Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potentialSolène-Florence Kammerer-Jacquet, Laurence Crouzet, Angélique Brunot, et al.
Cancers|September 10, 2021
Biomarker in Active Surveillance for Prostate Cancer: A Systematic ReviewCécile Manceau, Gaëlle Fromont, Jean-Baptiste Beauval, et al.
Annals of Surgical Oncology|July 15, 2016
Comparison of 1800 Robotic and Open Partial Nephrectomies for Renal TumorsBenoit Peyronnet, Thomas Seisen, Emmanuel Oger, et al.
World Journal of Urology|June 9, 2016
HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC)Francesco Soria, Marco Moschini, Andrea Haitel, et al.
European Urology Oncology|January 4, 2026
Results of the Randomized Phase 3 AFU-GETUG-20 Trial Evaluating Adjuvant Leuprorelin Acetate After Radical Prostatectomy in Men with High-risk Localized Prostate CancerFrançois Rozet, Alain Ruffion, Pablo Lemercier, et al.
World Journal of Urology|October 27, 2014
Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomyRomain Mathieu, Shahrokh F Shariat, Christian Seitz, et al.
World Journal of Urology|May 23, 2016
Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomyMihai Dorin Vartolomei, Romain Mathieu, Vitaly Margulis, et al.
World Journal of Urology|November 7, 2022
Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimensAlberto Martini, Alae Touzani, Jean-Baptiste Beauval, et al.
Pageof 23